D.E. Shaw & Co’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-119,123
| Closed | -$990K | – | 3248 |
|
|
2024
Q3 | $990K | Sell |
119,123
-364,437
| -75% | -$3.03M | ﹤0.01% | 2175 |
|
|
2024
Q2 | $3.46M | Sell |
483,560
-1,119,676
| -70% | -$8.02M | ﹤0.01% | 1459 |
|
|
2024
Q1 | $13.9M | Buy |
1,603,236
+370,737
| +30% | +$3.21M | 0.01% | 765 |
|
|
2023
Q4 | $8.07M | Buy |
1,232,499
+463,246
| +60% | +$3.03M | 0.01% | 970 |
|
|
2023
Q3 | $7.69M | Buy |
769,253
+200,971
| +35% | +$2.01M | 0.01% | 953 |
|
|
2023
Q2 | $7.06M | Sell |
568,282
-582,061
| -51% | -$7.24M | 0.01% | 1084 |
|
|
2023
Q1 | $16.1M | Sell |
1,150,343
-288,361
| -20% | -$4.04M | 0.02% | 688 |
|
|
2022
Q4 | $20.6M | Buy |
1,438,704
+621,160
| +76% | +$8.89M | 0.02% | 583 |
|
|
2022
Q3 | $20.9M | Buy |
817,544
+330,568
| +68% | +$8.44M | 0.02% | 543 |
|
|
2022
Q2 | $13.8M | Buy |
486,976
+106,595
| +28% | +$3.03M | 0.02% | 795 |
|
|
2022
Q1 | $13.4M | Buy |
380,381
+431
| +0.1% | +$15.2K | 0.01% | 909 |
|
|
2021
Q4 | $15.9M | Sell |
379,950
-264,852
| -41% | -$11.1M | 0.01% | 824 |
|
|
2021
Q3 | $31.6M | Buy |
644,802
+308,421
| +92% | +$15.1M | 0.03% | 515 |
|
|
2021
Q2 | $14M | Buy |
+336,381
| New | +$14M | 0.01% | 881 |
|